As a result, the company said it is targeting total sales of more than £40 billion by 2031, hiking its previous target of ...

About 800,000 Americans will have a heart attack or stroke this year. While heart disease can affect anyone, the risk substantially rises with age.

MRK provided 2025 adjusted EPS guidance of $8.88 to $9.03, while the giant drugmaker expects sales of $64.1 billion to $65.6 ...

The U.S. Food and Drug Administration (FDA), and the Office of Human Research protections (OHRP) released draft guidance titled, “Considerations ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Neurocrine's pipeline includes 12 clinical programs, with two Phase 3 trials due to report in 2025. See why I rate NBIX stock ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

FDA published two final guidance documents related to food allergens: Questions and Answers Regarding Food Allergens, ...

After repeated calls for action, the FDA has set a guideline for lead in baby food -- but it is not the end of the fight for ...

The alarm certainly sounded long and loud in 2022 when Abbott recalled Similac, Alimentum, and EleCare powdered infant formulas after an FDA investigation ...

If you are pregnant or nursing, talk with your health care professional about whether to enroll in pregnancy safety or ...

The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or ...